FIELD: pharmacology.
SUBSTANCE: invention relates to a carrier for delivering a substance to extracellular matrix producing cells in the kidney, the carrier consisting of a lipid structure containing a retinoid as a targeting agent, wherein the carrier has the form of a liposome. This invention also relates to a pharmaceutical composition for kidney fibrosis treatment, wherein the said carrier is used, to a method and a kit for its preparation.
EFFECT: increased means application effeciency.
8 cl, 3 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING RENAL FIBROSIS | 2011 |
|
RU2711531C2 |
| AGENT FOR TREATING MYELOFIBROSIS | 2009 |
|
RU2557997C2 |
| COMPOSITION FOR RECOVERY OF NORMAL TISSUE FROM FIBROUS TISSUE | 2011 |
|
RU2650796C2 |
| THERAPEUTIC AGENT APPLICABLE IN PULMONARY FIBROSIS | 2009 |
|
RU2547571C2 |
| MEANS FOR INTESTINAL FIBROSIS TREATMENT | 2012 |
|
RU2637372C2 |
| THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | 2015 |
|
RU2678968C2 |
| LIPOSOMS WITH RETYNOID TO STRENGTHEN hsp47 EXPRESSION MODULATION | 2012 |
|
RU2628694C2 |
| COMPOUNDS FOR TARGETED DRUG DELIVERY AND ENHANCING siRNA ACTIVITY | 2012 |
|
RU2769872C2 |
| COMPOUNDS FOR TARGETED DELIVERY OF MEDICINE AND ENHANCED SIPHK ACTIVITY | 2012 |
|
RU2632888C2 |
| THERAPEUTIC COMPOSITIONS AND METHODS AGAINST MALIGNANT TUMORS WITH RNAi MOLECULES DIRECTED AGAINST Hsp47 | 2015 |
|
RU2756253C2 |
